Screener
Citius Pharmaceuticals CTXR Q1 2026 earnings
Reported May 15, 2026 · Before market open
Revenue$1.7MMiss by $8.6M
EPS-$0.95Miss by $0.67
Revenue estimate$10.2M
EPS estimate-$0.28
Next report
Date not yet announcedVersus estimates
Revenue
Diluted EPS
FAQ
- When did Citius Pharmaceuticals report Q1 2026 earnings?
- Citius Pharmaceuticals (CTXR) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Citius Pharmaceuticals's Q1 2026 revenue and EPS?
- Citius Pharmaceuticals reported revenue of $1.7M and eps of $-0.95 for Q1 2026.
- Did Citius Pharmaceuticals beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $10.2M by $8.6M. EPS missed the consensus estimate of $-0.28 by $0.67.
- How did Citius Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 25.2% from $-1.27.
- Where can I find Citius Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-057876) and the 10-Q periodic report (0001213900-26-057842) directly on SEC EDGAR. The filing index links above go to sec.gov.
